MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer

Oncology Reports

Volumn 33, Issue 4, 2015, Pages 1707-1716

  Tang, Lin ^a   Chen, Feng ^b   Pang, Er Jun ^b   Zhang, Zhi Qi ^b   Jin, Bing Wei ^b   Dong, Wei Feng ^b  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

ANUBL1; Gastric cancer; MiR 182; Proliferation

Indexed keywords

ANUBL1 PROTEIN; MICRORNA 182; TUMOR PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ANUBL1 PROTEIN, HUMAN; MICRORNA; MIRN182 MICRORNA, HUMAN; RNA; RNA, RECOMBINANT; SMALL INTERFERING RNA;

ANUBL1 GENE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NEGATIVE FEEDBACK; ONCOGENE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN TARGETING; STOMACH CANCER; STOMACH CARCINOGENESIS; UPREGULATION; 3' UNTRANSLATED REGION; ADENOCARCINOMA; ADULT; AGED; BIOSYNTHESIS; CANCER GRADING; CELL CYCLE; DNA REPLICATION; FEEDBACK SYSTEM; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REPORTER GENE; RNA INTERFERENCE; STOMACH TUMOR; TUMOR STEM CELL ASSAY;

3' UNTRANSLATED REGIONS; ADENOCARCINOMA; ADULT; AGED; CELL CYCLE; DNA REPLICATION; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM PROTEINS; RNA; RNA INTERFERENCE; RNA, NEOPLASM; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 84924872872     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3798     Document Type: Article

References (26)

1. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Khushalani N: Cancer of the esophagus and stomach. Mayo Clin Proc 83: 712-722, 2008.
3. Kim JM, Sohn HY, Yoon SY, et al: Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin Cancer Res 11: 473-482, 2005.
4. Chen X, Leung SY, Yuen ST, et al: Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 14: 3208-3215, 2003.
5. Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854, 1993.
6. Pasquinelli AE, Reinhart BJ, Slack F, et al: Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408: 86-89, 2000.
7. Reinhart BJ, Slack FJ, Basson M, et al: The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906, 2000.
8. Li X, Zhang Y, Zhang Y, et al: Survival prediction of gastric cancer by a seven-microRNA signature. Gut 59: 579-585, 2009.
9. Ueda T, Volinia S, Okumura H, et al: Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11: 136-146, 2010.
10. Shimono Y, Zabala M, Cho RW, et al: Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138: 592-603, 2009.
11. Sun Y, Fang R, Li C, et al: Hsa-miR-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochem Biophys Res Commun 396: 501-507, 2010.
12. Kong WQ, Bai R, Liu T, et al: MicroRNA-182 targets cAMPresponsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS J 279: 1252-1260, 2012.
13. Bacus SS, Zelnick CR, Plowman G, et al: Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers. Implication for tumor biology and clinical behavior. Am J Clin Pathol 102 (Suppl 1): S13-S24, 1994.
14. Liao XH, Lu DL, Wang N, et al: Estrogen receptor ? mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway. FEBS J 281: 927-942, 2014.
15. Luo XG, Zou JN, Wang SZ, et al: Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells. IUBMB Life 62: 194-199, 2010.
16. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
17. Li Z, Zhan W, Wang Z, et al: Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via micoRNA suppressed reduces peritoneal metastasis. Biochem Biophys Res Commun 348: 229-237, 2006.
18. Gao C, Zhan Z, Liu W, et al: Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 116: 41-49, 2010.
19. Gregory RI and Shiekhattar R: MicroRNA biogenesis and cancer. Cancer Res 65: 3509-3512, 2005.
20. Song YX, Yue ZY, Wang ZN, et al: MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer 10: 1, 2011.
21. Ding L, Xu Y, Zhang W, et al: miR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 20: 784-793, 2010.
22. Kaji M, Yonemura Y, Harada S, et al: Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene Ther 3: 393-404, 1996.
23. Chen GY and Wang DR: The expression and clinical significance of CD44v in human gastric cancers. World J Gastroenterol 6: 125-127, 2000.
24. Tamura G, Kihana T, Nomura K, et al: Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res 51: 3056-3058, 1991.
25. Horii A, Nakatsuru S, Miyoshi Y, et al: The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res 52: 3231-3233, 1992.
26. Uchino S, Tsuda H, Noguchi M, et al: Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 52: 3099-3102, 1992.